Microbix Biosystems Net Income vs. Current Valuation
| MBX Stock | CAD 0.23 0.01 4.55% |
Net Loss | First Reported 1997-06-30 | Previous Quarter -1.6 M | Current Value -1.5 M | Quarterly Volatility 1.2 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.63 | 0.61 |
|
|
For Microbix Biosystems profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Microbix Biosystems to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Microbix Biosystems utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Microbix Biosystems's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Microbix Biosystems over time as well as its relative position and ranking within its peers.
Microbix |
Microbix Biosystems Current Valuation vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Microbix Biosystems's current stock value. Our valuation model uses many indicators to compare Microbix Biosystems value to that of its competitors to determine the firm's financial worth. Microbix Biosystems is considered to be number one stock in net income category among its peers. It is regarded fifth in current valuation category among its peers . Microbix Biosystems reported last year Net Loss of (2.58 Million). Comparative valuation analysis is a catch-all model that can be used if you cannot value Microbix Biosystems by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Microbix Biosystems' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Microbix Current Valuation vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Microbix Biosystems |
| = | (2.25 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Microbix Biosystems |
| = | 25.89 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Microbix Current Valuation vs Competition
Microbix Biosystems is regarded fifth in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 376.01 Million. Microbix Biosystems holds roughly 25.89 Million in current valuation claiming about 7% of equities under Health Care industry.
Microbix Biosystems Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Microbix Biosystems, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Microbix Biosystems will eventually generate negative long term returns. The profitability progress is the general direction of Microbix Biosystems' change in net profit over the period of time. It can combine multiple indicators of Microbix Biosystems, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 2.6 M | 2.7 M | |
| Operating Income | -1.8 M | -1.7 M | |
| Total Other Income Expense Net | -652.8 K | -685.5 K | |
| Net Loss | -2.6 M | -2.7 M | |
| Income Tax Expense | -50.2 K | -47.6 K | |
| Income Before Tax | -2.6 M | -2.5 M | |
| Net Loss | -2.6 M | -2.5 M | |
| Net Loss | -2.6 M | -2.5 M | |
| Net Interest Income | -685.3 K | -719.5 K | |
| Interest Income | 407.7 K | 428.1 K | |
| Change To Netincome | 1.1 M | 1.1 M | |
| Net Loss | (0.01) | (0.02) | |
| Income Quality | 0.03 | 0.03 | |
| Net Income Per E B T | 0.88 | 0.84 |
Microbix Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Microbix Biosystems. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Microbix Biosystems position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Microbix Biosystems' important profitability drivers and their relationship over time.
Microbix Biosystems Earnings per Share Projection vs Actual
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Microbix Biosystems without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Use Investing Themes to Complement your Microbix Biosystems position
In addition to having Microbix Biosystems in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run High Yield ETFs Thematic Idea Now
High Yield ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The High Yield ETFs theme has 109 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize High Yield ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Microbix Stock
To fully project Microbix Biosystems' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Microbix Biosystems at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Microbix Biosystems' income statement, its balance sheet, and the statement of cash flows.